Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03891667Phase 1Completed

Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease

Role: collaborator

NCT04457271Not ApplicableWithdrawn

Goal Management Training in Individuals With PTSD

Role: collaborator

NCT04654130Not ApplicableWithdrawn

Neurofeedback Effectiveness Trial in PTSD

Role: collaborator

All 3 trials loaded